In conclusion, our study identified miR-199a-5p could promote the progression of myocardial fibrosis after myocardial infarction by targeting GSK-3β, which plays an important role in the insulin signaling pathway, which provides novel targets for diagnosis and treatment of MF. This evidence concerns the gene GSK3B and Myocardial fibrosis.